Highlights: Type 2 diabetes mellitus (T2DM) patients have a significantly higher chance of developing cardiovascular diseases (CVD). Elecsys Cardiac NT-proBNP testing for CVD-risk assessment helps in the early detection and identification of T2DM patients most in need of cardioprotective treatment and supports clinical decision-making right from diagnosis to monitoring. Why Is Heart care important in Type 2 diabetes mellitus patients? T2DM is a rapidly rising concern in global healthcare, as it seriously impacts health and life expenditures, apart from patients’ quality of life (QoL).
1 Around 79.4 million people are predicted to be affected by this heterogenous disease in India by 2030. 2,3 With the rising number of T2DM patients comes the increased risk of associated cardiovascular conditions. It is estimated that up to 46% of T2DM patients will develop some form of cardiovascular…
